Polydex Pharmaceuticals Ltd (OTC Pink - Limited Information:POLXF)

1.13
Delayed Data
As of Aug 16
 0.00 / 0.00%
Today’s Change
0.75
Today|||52-Week Range
1.29
+39.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Revenue and IncomeNet Revenues6.0M6.6M5.3M4.9M
 
 
 
 
 
Cost of Goods Sold4.4M4.6M3.7M3.7M
 
 
 
 
 
Depreciation And Amortization203.0K218.3K250.2K275.3K
 
 
 
 
 
 
Operating ExpensesGross Income1.4M1.8M1.3M920.4K
 
 
 
 
 
General Expenses901.5K821.3K714.4K682.9K
 
 
 
 
 
Research And Development573.00598.004.0K0.00
 
 
 
 
Total Operating Expenses5.5M5.6M4.7M4.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income542.0K988.3K573.2K237.5K
 
 
 
 
 
Interest Expense On Debt42.6K38.0K33.8K35.0K
 
 
 
 
 
Other Expenses194.1K-101.6K-75.9K-36.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.1M855.9K481.8K169.7K
 
 
 
 
 
Income Taxes-201.1K-186.7K-33.8K-61.2K
 
 
 
 
 
Net Income1.3M669.3K448.0K230.9K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.3M3.4M3.4M3.4M
 
 
 
 
 
Shares To Calculate EPS Diluted3.5M3.5M3.5M3.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.38$0.20$0.13$0.07
 
 
 
 
 
EPS Diluted$0.37$0.19$0.13$0.07